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Introduction {#sec1}
============

Skeletal muscle has the remarkable ability to modulate its mass in response to the physiological changes associated with functional use, nutrient availability, systemic disease, and age. Under normal physiological conditions, skeletal muscle maintains its mass through a complex balance of anabolic and catabolic signaling ([@bib26]). However, cachexia, metabolic dysfunction, muscular dystrophy, and advanced age lead to a disequilibrium between anabolic and catabolic signaling resulting in muscle dysfunction and atrophy ([@bib13]; [@bib18]; [@bib20]; [@bib48]; [@bib60]). IGF-1/PI3K/Akt signaling has emerged as a key regulator of skeletal muscle hypertrophic growth and metabolism through its activation of mTOR-dependent anabolic processes while simultaneously inhibiting Foxo1/3-dependent catabolic processes ([@bib47]). Transgenic overexpression of Akt1 in skeletal muscle promotes muscle hypertrophy ([@bib38]), and its selective expression in glycolytic muscles promotes insulin sensitivity in aged mice that display impaired Akt activation ([@bib1]). mTOR signals through two complexes, the mTOR containing complex 1 (mTORC1), which both activates anabolic processes while inhibiting autophagy, and the mTOR containing complex 2 (mTORC2), which is the primary Akt1 Ser473 kinase ([@bib47]). Although the molecular regulation is complex, changes in Akt and mTOR signaling contribute to metabolic derangements and muscle wasting ([@bib10]; [@bib63]; [@bib67]).

Alternative splicing is a key gene regulatory mechanism whereby the differential inclusion of exons results in multiple mRNA isoforms from a single genomic locus. This process plays a crucial role in the post-transcriptional regulation of gene and protein isoform expression ([@bib40]) and is differentially regulated in response to cellular stress ([@bib5]; [@bib15]). Current analyses indicate that \>95% of human multi-exon genes are subject to alternative splicing ([@bib58]). Brain, heart, and skeletal muscle have the highest levels of evolutionary conserved alternatively spliced transcripts ([@bib52]) and are subject to multiple disorders due to mis-splicing events ([@bib21]; [@bib68]). Alternative splicing in skeletal muscle plays a crucial role in muscle development, and genetic mutations in both splice sites and the RNA binding proteins that modulate splicing play causal roles in the pathogenesis of neuromuscular disorders ([@bib29]; [@bib43]; [@bib61]; [@bib65]). In addition, dysregulated splicing is increasingly recognized as a causal factor promoting cellular dysfunction through changes in the binding properties, enzymatic activities, and intracellular localization of a large percentage of the proteome ([@bib74]). However, our understanding of how alternative splicing modulates the activity of IGF-1/PI3K/Akt signaling in skeletal muscle physiology is limited.

The functionally diverse heteronuclear ribonucleoprotein (hnRNP) family of RNA-binding proteins play key roles in RNA metabolism including mRNA stabilization and the regulation of alternative splicing ([@bib25]; [@bib49]). Genetic mutations and dysregulated expression of hnRNPs A1, E1/2 (PCBP1/2), I (PTBP1), P2 (FUS), and Q (SYNCRIP) are implicated in the molecular pathogenesis of neuromuscular disorders including myotonic and limb girdle muscular dystrophy, amyotrophic lateral sclerosis, and spinal muscle atrophy ([@bib25]; [@bib41]; [@bib76]). HnRNP family member U (hnRNP-U) is the largest member of the hnRNP family, ubiquitously expressed, and known to modulate both mRNA stability and alternative splicing ([@bib30]; [@bib80]; [@bib86]). Clinically, heterozygous loss-of-function mutations in the *Hnrnpu* gene are associated with craniofacial anomalies, developmental delays, and seizures ([@bib83]). In mice, genetic deletion of *Hnrnpu* specifically within cardiomyocytes leads to a dilated cardiomyopathy phenotype around postnatal day 14 ([@bib84]). Here, we identify hnRNP-U as being essential for skeletal muscle hypertrophic growth, in part, through modulating the balance between Akt1-dependent anabolic signaling and the energy and nutrient availability to support hypertrophic growth. hnRNP-U expression is repressed with age and necessary for the proper expression and splicing of genes critical for metabolic and growth processes.

Results {#sec2}
=======

The Development and Early Postnatal Growth of Skeletal Muscle Is Phenotypically Normal in the Absence of Hnrnpu {#sec2.1}
---------------------------------------------------------------------------------------------------------------

The hnRNP-U protein is expressed in nearly all tissues examined in the adult mouse ([Figure 1](#fig1){ref-type="fig"}A). However, the expression of hnRNP-U in skeletal muscle decreases abruptly in aged mice ([Figure 1](#fig1){ref-type="fig"}B). To study the role of hnRNP-U in skeletal muscle growth and function, we crossed Hnrnpu^fl/fl^ mice ([@bib84]) with a mouse line expressing the Cre recombinase under the control of the human skeletal actin promoter (HSA-Cre). HSA-Cre expression starts at E8.5 and continues into adulthood ([@bib53]). Consistent with a prior report in which *Hnrnpu* was deleted in both cardiac and skeletal muscle during development ([@bib84]), Hnrnpu^fl/fl^;HSA-Cre (mKO) mice are born in normal Mendelian ratios with no observable abnormalities ([Figure S1](#mmc1){ref-type="supplementary-material"}). However, in contrast with this prior report, *Hnrnpu* mKO mice continue to develop normally past postnatal day 14 (P14). Western blot analysis indicates \~50% reduction in hnRNP-U expression in Hnrnpu mutants at P21 ([Figure 1](#fig1){ref-type="fig"}C). Laminin stained sections of P21 *Hnrnpu* mutant gastrocnemius (GSN, [Figure 1](#fig1){ref-type="fig"}D) and soleus ([Figure 1](#fig1){ref-type="fig"}G) are morphologically indistinguishable from littermate controls. Although subtle differences are observed in the myofiber size distribution curves of the gastrocnemius ([Figure 1](#fig1){ref-type="fig"}E) and soleus ([Figure 1](#fig1){ref-type="fig"}H), there are no statistically significant differences in the average myofiber cross-sectional areas ([Figures 1](#fig1){ref-type="fig"}F and 1I). Furthermore, we observe no differences in the morphology, myofiber size distribution, or the average myofiber cross-sectional area of the tibialis anterior (TA) of Hnrnpu mKO mice at P21 ([Figure S2](#mmc1){ref-type="supplementary-material"}). Collectively, these data indicate embryonic deletion of *Hnrnpu* does not measurably impact the development or post-natal growth of skeletal muscle up to \~P21.Figure 1*Hnrnpu* mKO Mice Are Born Phenotypically Normal(A) Representative western blots of relative hnRNP-U expression in adult mouse tissues. Data are from n = 2 biological replicates.(B) Representative western blot and quantification of hnRNP-U expression in the gastrocnemius with advancing age. Data are from n = 3 WT male mice at 3 and 12 months of age, and n = 2 WT male mice at 24 months of age.(C) Western blot of hnRNP-U expression in gastrocnemius muscle at P21.(D--I) Data are from n = 3 control and n = 3 mKO male mice at P21. (D--F) Immunohistological analyses of gastrocnemius muscle. (G--I) Immunohistological analyses of soleus muscle. (D and G) Laminin staining of muscle transverse sections. The scale bar is 50 μm. (E and H) Myofiber size distribution curves. (F and I) Average myofiber cross-sectional areas. Data are mean ± standard deviation. Significance (∗) was set at p \< 0.05. p Values were calculated using the Student\'s two-tailed t test assuming unequal variances.

Hnrnpu mKO Mice Develop a Severe Adult-Onset Myopathy {#sec2.2}
-----------------------------------------------------

To explore the role of *Hnrnpu* on skeletal muscle and whole-body growth, we performed longitudinal body weight analyses starting at P21. Consistent with our analyses of mice at P21 ([Figure 1](#fig1){ref-type="fig"}), male and female mKO mice are indistinguishable by weight from littermate controls up to approximately 4 weeks of age ([Figure 2](#fig2){ref-type="fig"}A). Growth curve analyses indicate that *Hnrnpu* mKO mice reach a body weight plateau at approximately 11--13 weeks of age, with statistically significant reductions in the body weights of males and females by 6- and 12-weeks of age, respectively. Male and female *Hnrnpu* mutants become visually distinguishable from control littermates by 10--12 weeks and 16--18 weeks, respectively. Functional assessments at 3 months of age indicate that *Hnrnpu* mutants have significant reductions in grip strength ([Figure 2](#fig2){ref-type="fig"}B) and maximal running speed ([Figure 2](#fig2){ref-type="fig"}C). Consistent with these analyses, the normalized muscle mass of *Hnrnpu* mutants is observed to be significantly reduced with respect to littermate controls ([Figure 2](#fig2){ref-type="fig"}D).Figure 2*Hnrnpu* mKO Mice Develop Adult-Onset Myopathy(A) Growth curves of male and female mice. Data are mean ± SEM from 25--40 mice per genotype, depending on age and gender.(B) Grip strength.(C) Maximum running speed.(D) Normalized muscle wet weight.(B--D) Data are mean ± standard deviation from n = 8 control and n = 8 mKO male mice. Significance (∗) was set a p \< 0.05.(E--I) Histological analyses of *Hnrnpu* mutant and control littermates at 3 months of age.(E) H&E staining of *Hnrnpu* mutant gastrocnemius muscle. The scale bar is 50 μm.(F) H&E staining of tibialis anterior. The scale bar is 50 μm.(G) Quantification of central nuclei in tibialis anterior. Data are from n = 9,785 control and n = 9,921 mutant myofibers from n = 7 male mice per group. Data are mean ± standard deviation. Significance (∗) was set at p \< 0.05.(H) Masson\'s Trichrome staining of tibialis anterior and gastrocnemius. The scale bar is 50 μm.(I) Quantification of percent fibrotic area. Data are mean ± standard deviation from n = 3 control and n = 3 male mKO mice. Significance (∗) was set at p \< 0.05. p Values were calculated using the Student\'s two-tailed t test assuming unequal variances.

Histological examination of muscles from *Hnrnpu* mutants at 3 months of age reveals central nuclei, myofiber degeneration and necrosis, intracellular inclusions, and extensive fibrosis ([Figures 2](#fig2){ref-type="fig"}E--2I). H&E staining of *Hnrnpu* mutant gastrocnemius muscles reveals the accumulation of mononuclear cells and intracellular inclusions ([Figure 2](#fig2){ref-type="fig"}E). In the TA we observe myofiber degeneration, intracellular inclusions, and abundant central nuclei ([Figure 2](#fig2){ref-type="fig"}F). Quantification of H&E images indicate that 6.45 ± 1.88% of TA myofibers in *Hunrnpu* mutants contain central nuclei as compared with 0.19 ± 0.24% of control myofibers ([Figure 2](#fig2){ref-type="fig"}G). Masson\'s Trichrome staining of both the TA and gastrocnemius muscles indicate that *Hnrnpu* mutants have extensive fibrosis ([Figure 2](#fig2){ref-type="fig"}H). Quantification of Masson\'s staining indicate that the fibrotic area of TA and gastrocnemius muscles increase from 4.0 ± 0.67% and 3.4 ± 0.89% in controls to 11.8 ± 2.13% and 20.3 ± 4.78% in *Hnrnpu* mutants ([Figure 2](#fig2){ref-type="fig"}I), respectively. As *Hnrnpu* mutants age, female mice present with pronounced kyphosis by 5 months, whereas males develop a less severe form by 7 months ([Figure S3](#mmc1){ref-type="supplementary-material"}).

To further characterize the muscle architecture of Hnrnpu mutants, we next performed quantitative analyses of myofiber cross-sectional areas. Immunofluorescence labeling of laminin and quantification of gastrocnemius myofiber cross-sectional areas indicate myofiber atrophy in mutant mice, as indicated by an elevated leftward shift of the myofiber size distribution curve ([Figures 3](#fig3){ref-type="fig"}A and 3B). Quantitatively, data indicate a significant 21.2% decrease (1479 ± 29 versus 1878 ± 150 μm^2^, p = 0.011, mKO versus control) in the average gastrocnemius myofiber cross-sectional area of individual mice ([Figure 3](#fig3){ref-type="fig"}C). In contrast, the tibialis anterior has only a subtle leftward shift of the myofiber size distribution curve ([Figures 3](#fig3){ref-type="fig"}D and 3E), whereas the soleus is virtually indistinguishable ([Figures 3](#fig3){ref-type="fig"}G and 3H) between mKO and littermate controls. Although we observe decreases of 7.9% (1,541 ± 76 versus 1,674 ± 114 μm^2^, p = 0.058, mKO versus control) and 3.3% (725 ± 94 versus 701 ± 98 μm^2^, p = 0.537, mKO versus control) in the tibialis anterior ([Figure 3](#fig3){ref-type="fig"}F) and soleus ([Figure 3](#fig3){ref-type="fig"}I), respectively, these differences fail to reach statistical significance. Consistent with these observations, NMR body composition analyses indicate a significant decrease in the lean muscle mass of *Hnrnpu* mutants as compared with littermate controls ([Table 1](#tbl1){ref-type="table"}). Collectively, these observations indicate that the loss of *Hnrnpu* results in a multifaceted myopathy characterized by histological features of myofiber necrosis and inclusions, central nuclei, extensive fibrosis, and muscle wasting.Figure 3Selective Muscle Wasting in *Hnrnpu* Mutants(A--C) Immunohistological analyses of gastrocnemius muscle.(D--F) Immunohistological analyses of tibialis anterior muscle.(F--I) Immunohistological analyses of soleus muscle.(A, D, and G) Laminin staining of muscle transverse sections. The scale bar is 50 μm.(B, E, and H) Myofiber size distribution curves.(C, F, and I) Average myofiber cross-sectional areas.(A--I) Data are from n = 4 control and n = 4 mKO male mice at 3 months of age. Data are mean ± standard deviation. Significance (∗) was set at p \< 0.05. p Values were calculated using the Student\'s two-tailed t test assuming unequal variances.Table 1NMR Body Composition Parameters of Hnrnpu mKO Mice at 3 Months of AgeWT (n = 7)mKO (n = 7)p ValueBody weight (g)28.61 ± 1.4625.70 ± 1.390.014Fat (g)3.45 ± 0.523.44 ± 0.570.995Lean (g)24.26 ± 1.5021.33 ± 1.510.019Free water (g)0.17 ± 0.100.14 ± 0.080.604**Total water (g)18.31 ± 1.0314.94 ± 1.140.003**[^3]

Hnrnpu Mutant Mice Have an Impaired Regenerative Response {#sec2.3}
---------------------------------------------------------

The decreased lean muscle mass and leftward shift of myofiber size distribution, in conjunction with an increase in myofibers with centrally located nuclei, prompted us to evaluate the capacity for myofiber regeneration following injury in *Hnrnpu* mutant mice. Morphometric analysis of wild-type (WT) control mice 10 days post injury (DPI) depicts robust regeneration characterized by large well-organized myofibers. In contrast, mKO mice exhibit an impaired regenerative response as indicated by numerous small poorly organized myofibers ([Figure 4](#fig4){ref-type="fig"}A). Quantitative analyses of histological sections indicate a leftward shift in the myofiber size distribution curve of newly regenerated myofibers in mKO mice relative to controls ([Figure 4](#fig4){ref-type="fig"}B). To explore whether the age-associated loss of hnRNP-U ([Figure 1](#fig1){ref-type="fig"}B) contributes to the regenerative deficits of aged muscles ([@bib14]), we performed the cryoinjury model on young (3 months) and old (24--26 months) C57BL/6 WT mice. Morphometric analyses of H&E-stained sections obtained from young mice exhibit a robust regenerative response at 10 DPI as evidenced by large well-organized regenerated myofibers, whereas old mice exhibit a weak regenerative response characterized by small, poorly organized myofibers ([Figure 4](#fig4){ref-type="fig"}C). Quantitative analyses of histological sections indicate a leftward shift in the myofiber size distribution curve of newly regenerated myofibers in aged mice relative to young controls ([Figure 4](#fig4){ref-type="fig"}D). Overall, the newly regenerated myofibers of young mKO mice are 32% smaller (903 ± 261 versus 1,339 ± 174, mKO versus control) than littermate controls, whereas the newly regenerated myofibers of old C57BL/6 WT mice are 35% smaller (833 ± 44 versus 1,298 ± 168 μm^2^, old versus young) than young C57BL/6 controls ([Figure 4](#fig4){ref-type="fig"}E). Collectively, these observations indicate that *Hnrnpu* mutants have a regenerative response with many similarities to that of aged mice, suggesting that the loss of hnRNP-U in advanced age may contribute to regenerative impairments.Figure 4Young *Hnrnpu* mKO Mice Phenocopy the Regenerative Response of Old Mice(A) H&E-stained transverse sections of young (3 months) control and mKO tibialis anterior muscle 10 days post injury. The scale bar is 50 μm.(C) H&E-stained transverse sections of young (3 months) and old (26 months) tibialis anterior muscles 10 days post injury. The scale bar is 50 μm.(B) Myofiber size distribution curve of regenerating myofibers from (A).(D) Myofiber size distribution curve of regenerating myofibers from (C).(E) Dot plot of average regenerated myofiber cross-sectional area from n = 7 young *Hnrnpu* control (black diamond), n = 7 young male *Hnrnpu* mKO (red diamond), n = 6 young C57BL/6 (blue diamond), and n = 6 old male C57BL/6 mice (green diamond). Bars are mean ± standard deviation. Significance (∗) was set at p \< 0.05. p Values were calculated using the Student\'s two-tailed t test assuming unequal variances.

Loss of Hnrnpu Leads to Dysregulated Expression and Splicing of Metabolic Genes {#sec2.4}
-------------------------------------------------------------------------------

To better understand the molecular processes underlying our observations, we performed whole transcriptome gene and splice variant expression analyses on the gastrocnemius muscles of mice at 3 months of age. We obtained \>60 million strand-specific 150-bp paired-end reads per sample with at least 91% of reads mapping to the mouse genome. Differential gene expression (log2FoldChange ±1.0, padj \<0.01) analysis indicate 1,171 and 786 genes are increased and decreased in expression (mKO versus control), respectively ([Figure 5](#fig5){ref-type="fig"}A). Quantitative PCR validation of RNA sequencing (RNA-seq) analyses (data not shown) indicate a marked reduction in the expression of Myostatin, as well as a general repression of the E3 ubiquitin ligases and accessory proteins known to promote muscle atrophy ([@bib6]; [@bib56]; [@bib66]). In addition, genes associated with increased energy expenditures and metabolic stress, including *Sln*, *Asns*, *Fgf21*, *Gdf15*, *Psat1*, and *Mthfd2* ([@bib3]; [@bib11]; [@bib22]; [@bib51]; [@bib54]), are robustly induced in the muscles of *Hnrnpu* mutants ([Figure 5](#fig5){ref-type="fig"}B). Interestingly, the induction of long non-coding RNAs (lncRNAs) appears to portend muscle atrophy and/or metabolic dysfunction, as we observe \>3-fold more lncRNAs to be induced (Log2FoldChange \>2, padj \<0.01), rather than repressed. To better understand the cellular and molecular processes impacted by the changes in gene expression we performed Gene Ontology enrichment analysis. Our analysis indicates that up-regulated genes are highly associated with inflammatory signaling ([Figure S4](#mmc1){ref-type="supplementary-material"}A), whereas downregulated genes are associated with energy production and metabolic processes ([Figure S4](#mmc1){ref-type="supplementary-material"}B). Specifically, we note the marked repression of *Mss51* (Zmynd17), which acts as an inhibitor of oxidative metabolism ([@bib64]), multiple solute transporters with roles in amino acid and anion/cation (*Slc15a5*, *Slc30a2, Slc40a1*, *Slc4a10*) homeostasis ([@bib42]), as well as multiple enzymes involved in the biogenesis of triacylglycerol (*Dgat2l6*) ([@bib85]), amino acids (*Gadl1*, *Padi2*, *Amd1/2*), and glycogen (*Gys2*) ([Figure 5](#fig5){ref-type="fig"}C). The top induced and repressed genes in the gastrocnemius of mKO mice are listed in [Table S1](#mmc2){ref-type="supplementary-material"}.Figure 5Gene Expression and Alternative Splicing Are Dysregulated in *Hnrnpu* mKO Mice(A) Whole-genome expression profile of male *Hnrnpu* mutant gastrocnemius. Red and blue dots depict increased and decreased gene expression (mKO versus control, padj \<0.01), respectively. Decreased (blue) and increased (red) expression of genes in *Hnrnpu* mutant gastrocnemius associated with (B) muscle atrophy and metabolic stress, and (C) energy production and nutrient transport.(B and C) Data are Log~2~(FoldChange) ± standard error. Significance (∗) was set at p \< 0.0001. p Values were calculated using the Wald test corrected for multiple testing using the Benjamini-Hochberg method.(D) Summary of significant differential splicing events between genotypes. \|ΔPSI\| \> 0.1, FDR \< 0.01.(E) Whole-genome expression profiling of mis-spliced differentially expressed genes in (A). Dots represent individual splicing events occurring on differentially expressed genes. Statistically significant splicing events (FDR \< 0.01) occurring on statistically significant differentially expressed genes (padj \<0.01) are highlighted in red. p Values were calculated using a likelihood-ratio test.(F--J) Examples of differential splicing regulated by hnRNP-U: *Senp1* (F), *Setd3* (G), *Mff* (H), *Sorbs1* (I), and *Inpp4a* (J). SE, Skipped Exon; RI, Retained Intron; MXE, Mutually Exclusive Exon; A3SS, Alternative 3′ Splice Site; A5SS, Alternative 5′ Splice Site.

We next examined the impact of *Hnrnpu* deletion on alternative splicing from the strand-specific paired-end RNA-seq data. Using the rMATS program for splicing analysis ([@bib71]), we identified 2,909 significant alternative splicing events (\|ΔPSI\| \> 0.1, false discovery rate \[FDR\] \< 0.01; [Table S2](#mmc3){ref-type="supplementary-material"}). The distribution of these events, which include skipped exons (SEs), retained introns (RIs), mutually exclusive exons (MXEs), and the use of alternative 5' (A5SS) and 3' (A3SS) splice sites, is shown in [Figure 5](#fig5){ref-type="fig"}D. These data show that loss of hnRNP-U leads to extensive dysregulation of exon utilization in which SE (74.2%) and MXE (11.7%) events far exceed the utilization of alternative exons (A5SS and A3SS), suggesting that hnRNP-U may be involved in defining intron/exon boundaries. This is in contrast with a prior study in the developing heart, in which RI events were the largest share of alternative splicing events following the loss of hnRNP-U ([@bib84]), thus suggesting that the role of hnRNP-U in pre-mRNA splicing modulation is differentially regulated in a cell type- and context-dependent manner. Coupled with the differential gene expression analysis, we observe 1,296 mis-splicing events (FDR \< 0.01) across 710 genes whose expression is significantly altered (padj \<0.01) in the absence of *Hnrnpu* ([Figure 5](#fig5){ref-type="fig"}E). The majority of these events occur on genes whose expression is decreased (985 events across 529 genes) as compared with those that are increased (311 events across 181 genes). Splicing events in mKO mice are biased toward exclusion (ΔPSI, quadrant I: 228 events across 150 genes, quadrant IV: 653 events across 388 genes) rather than inclusion (-ΔPSI, quadrant II: 83 events across 56 genes, quadrant III: 332 events across 218 genes). To better understand the cellular and molecular processes impacted by the changes in alternative splicing, we again performed Gene Ontology enrichment analysis. Our analysis indicates that genes with the differential inclusion/exclusion of exons (\|ΔPSI\| \> 0.1, FDR \< 0.01) are highly associated with metabolic and signal transduction processes ([Figure S4](#mmc1){ref-type="supplementary-material"}C). In addition, Gene Ontology enrichment analysis of genes that are both downregulated and mis-spliced ([Figure 5](#fig5){ref-type="fig"}E) similarly indicate that this subset of genes is highly associated with metabolic and signal transduction processes ([Figure S4](#mmc1){ref-type="supplementary-material"}D).

A more detailed examination of altered splicing events revealed that hnRNP-U is necessary for normal exon utilization in multiple genes, including *Senp1* ([Figure 5](#fig5){ref-type="fig"}F), *Setd3* ([Figure 5](#fig5){ref-type="fig"}G), *Mff* ([Figure 5](#fig5){ref-type="fig"}H), *Sorbs1* ([Figure 5](#fig5){ref-type="fig"}I), and *Inpp4a* ([Figure 5](#fig5){ref-type="fig"}J). The Sentrin/SUMO-specific protease 1 (*Senp1*) has been previously shown to be involved in regulating mitochondrial biogenesis through enhancing PGC-1α activity ([@bib9]), whereas mitochondrial fission factor (*Mff*) is a critical regulator of mitochondrial dynamics ([@bib57]). Expression of SET domain containing methyltransferase 3 (*Setd3*) is positively correlated with skeletal muscle hypertrophy ([@bib69]) and involved in muscle differentiation via promoting the expression of the myogenic regulatory factors MyoG and Myf6 ([@bib19]). Sorbin and SH3 domain containing protein 1 (*Sorbs1*) is required for PI3K-independent, insulin-stimulated glucose uptake ([@bib4]), whereas the inositol polyphosphate-4-phosphatase 1A (*Inpp4a*) is a PIP2 phosphatase impairing Akt activation ([@bib31]). Collectively, these data indicate that *Hnrnpu* is required for the expression and splicing of genes involved in the signal transduction and metabolic processes crucial for normal skeletal muscle growth.

Akt Signaling Is Constitutively Active in Hnrnpu Mutants {#sec2.5}
--------------------------------------------------------

To further explore the impact of *Hnrnpu* deletion on the signal transduction and metabolic processes underlying the muscle wasting in *Hnrnpu* mutants, we examined IGF-1/PI3K/Akt signaling. To begin, we injected either saline or recombinant IGF-1 into the gastrocnemius muscles of control and mutant mice at \~4 months of age. Quantitative western blot analyses indicate that IGF-1 receptor (IGF-1R) autophosphorylation in response to IGF-1 administration is similar between *Hnrnpu* mutant and control mice ([Figures 6](#fig6){ref-type="fig"}A and 6B), suggesting that initiation of the IGF-1/PI3K/Akt1 signaling cascade is intact in the absence of *Hnrnpu*. Upon examination of Akt1 phospho-activation, we observe that IGF-1 stimulation induces a robust induction in Akt1 phosphorylation at Ser473 in control mice ([Figures 6](#fig6){ref-type="fig"}A and 6C), indicating that IGF-1 stimulation results in the phospho-activation of Akt1. In contrast, we observe that the level of Akt1 Ser473 phosphorylation in vehicle-treated *Hnrnpu* mutant mice is comparable with that of IGF-1-stimulated controls ([Figure 6](#fig6){ref-type="fig"}A). In addition, IGF-1 stimulation is unable to induce further Akt1 Ser473 phosphorylation ([Figure 6](#fig6){ref-type="fig"}A) suggesting that Akt1 is maximumly activated under normal physiological conditions at this time point. Quantification of the phospho-Ser473 to total Akt1 ratio confirms this observation ([Figure 6](#fig6){ref-type="fig"}C), although the decreased magnitude of the phospho:total Akt1 ratio relative to IGF-1 stimulated controls is due to the increased expression of Akt1 in *Hnrnpu* mutant mice ([Figure 6](#fig6){ref-type="fig"}D). Collectively, these observations indicate that, in the absence of *Hnrnpu*, Akt1 becomes constitutively activated and thus desensitized to IGF-1/PI3Ksignaling.Figure 6Constitutive Activation of Akt1 and Impaired Autophagic Flux in *Hnrnpu* mKO Mice(A) Representative western blots of gastrocnemius muscle lysates 1 h following injection of IGF-1.(B--D) Quantification of (A). Data are mean ± standard deviation from n = 3 independent experiments and are normalized to WT vehicle controls. Significance (∗) was set at p \< 0.05. p Values were calculated using the Student\'s two-tailed t test assuming unequal variances.(E and G) Representative western blots of unstimulated gastrocnemius muscles at 3 months of age.(F and H) Quantification of (E) and (G), respectively. Data are mean ± standard deviation from n = 3 biological samples per genotype and are normalized to WT controls. Significance (∗) was set at p \< 0.05. p Values were calculated using the Student\'s two-tailed t test assuming unequal variances.(I) Representative western blots of unstimulated gastrocnemius muscles at P21. Male mice were used for all analyses.

Following up on these observations, we asked whether the signaling downstream of IGF-1R was biased toward Akt1 activation. First, we examined the expression of the PI3K p110 catalytic subunit. Quantitative western blot analyses indicate that *Hnrnpu* mutant mice express \~70% more p110 than WT controls ([Figures 6](#fig6){ref-type="fig"}E and 6F). We next examined PTEN, as it is well established to oppose the Akt1 activating actions of PI3K ([@bib39]; [@bib67]). Counterintuitively, we observe the expression of PTEN to be increased \>4-fold in the gastrocnemius of *Hnrnpu* mutant mice as compared with controls ([Figures 6](#fig6){ref-type="fig"}E and 6F). These observations and the accompanying reductions in body weight ([Figure 2](#fig2){ref-type="fig"}C) are consistent with a prior report indicating that increases in PTEN protein expression induce postnatal growth impairments through increases in energy expenditure ([@bib24]). Interestingly, the increases in both IGF-1R and Akt1 protein expression are positively correlated with increases in *Igf1r* (Log2FC = 0.70 ± 0.14, padj = 9.93 × 10^−6^, mKO versus WT) and *Akt1* (Log2FC 0.40 ± 0.16, padj = 0.03, mKO versus WT), whereas the increase in PTEN protein is negatively correlated with *Pten* (Log2FC −0.65 ± 0.13, p = 9.67 × 10^−9^, mKO versus WT) expression. Together, these observations suggest that the increase in IGF-1R and Akt1 protein expression contribute to the observed dysregulation of Akt1 activation and that post-transcriptional gene regulation of mature mRNA may also be altered in the absence of *Hnrnpu*.

*Hnrnpu* mKO mice share many similarities with the phenotypes of mice in which *Tsc1* ([@bib10]) and *Atg7* ([@bib50]) were selectively deleted in skeletal muscle, prompting us to evaluate the downstream effects of Akt signaling on autophagy. Initiated by the essential positive regulator ULK1, and negatively regulated by Akt/mTORC1 signaling, autophagy plays crucial roles in both the maintenance of cellular metabolic homeostasis and the cellular response to stress ([@bib62]). We observe a nearly 4-fold induction of ULK1 phosphorylation at Ser757 ([Figures 6](#fig6){ref-type="fig"}G and 6H) indicating an inhibition of autophagy initiation through mTORC1-dependent mechanism ([@bib35]; [@bib47]). To further corroborate this observation, we assayed for the autophagy-specific substrate and cargo receptor SQSTM1/p62, the accumulation of which is used as an indicator of autophagy impairment ([@bib36]). Consistent with this, we observe a marked increase in the expression of SQSTM1/p62 ([Figure 6](#fig6){ref-type="fig"}G) in *Hnrnpu* mutants as compared with controls, further corroborating our observations of autophagy impairment in the absence of *Hnrnpu*. Together, these data indicate that the constitutive activation of Akt leads to an increase in mTORC1-mediated inhibition of autophagy.

The postnatal growth of skeletal muscle up to \~P21 is primarily due to the satellite cell contributions to myofiber volume and myonuclei content, after which myonuclear and satellite cell content stabilizes and hypertrophic signaling begins to dominate ([@bib78]). As such, we sought to determine whether the satellite cell contributions to muscle growth at this time point masked PI3K/Akt signaling derangements. Quantitative western blot analyses of gastrocnemius muscles of control and mKO mice at P21 indicate no significant differences in the expression or activation of IGF-1R, PI3K p110, Akt1, and PTEN ([Figure 6](#fig6){ref-type="fig"}I), indicating the IGF-1/PI3K/Akt signaling is unaltered in *Hnrnpu* mutants at this time point. In addition, the SQSTM1/p62 protein expression in WT and *Hnrnpu* mutants at P21 ([Figure 6](#fig6){ref-type="fig"}I) is comparable with that of *Hnrnpu* mutants at 3 months of age ([Figures 6](#fig6){ref-type="fig"}G and [S5](#mmc1){ref-type="supplementary-material"}). Collectively, these data indicate that *Hnrnpu* is essential for the normal physiological activation of Akt signaling and its responsiveness to IGF-1 stimulation.

Discussion {#sec3}
==========

The dysregulation of IGF-1/PI3K/Akt/mTOR signaling is associated with a diverse array of pathological conditions including cancer, cardiovascular disease, inflammatory and autoimmune disorders, and insulin resistance and type 2 diabetes ([@bib47]; [@bib67]). In skeletal muscle, Akt signaling is a key regulator of glycolytic muscle homeostasis, hypertrophic growth, and metabolism through its activation of mTOR-dependent anabolic processes and simultaneous inhibition of catabolic processes. Alternative splicing plays a crucial role in muscle development, as genetic mutations in both splice sites and RNA-binding proteins involved in splicing regulation playing causal roles in the pathogenesis of neuromuscular disorders ([@bib29]; [@bib43]; [@bib61]; [@bib65]). We demonstrate that skeletal muscle-specific deletion of *Hnrnpu* leads to an adult-onset myopathy with selective muscle wasting, fibrosis, and broad changes in both the expression and splicing of genes. In addition, dysregulated splicing is increasingly recognized as a causal factor promoting cellular dysfunction through changes in the binding properties, enzymatic activities, and intracellular localization of a large percentage of the proteome ([@bib74]). Accordingly, our data in the muscles of *Hnrnpu* mutants demonstrate the constitutive activation of Akt signaling and its desensitization to IGF-1 stimulation. Of the individual muscles analyzed, the soleus was the only muscle without changes in myofiber cross-sectional area. This is in contrast with the non-significant trend and the significantly marked reduction in myofiber cross-sectional areas observed in the tibialis anterior and gastrocnemius, respectively. Although the cellular adaptations underlying the distinct growth responses to *Hnrnpu* deletion in each of these muscles are unclear, differences in functional utilization (e.g., ankle extensor versus ankle flexor) as well as metabolic adaptations specific to each individual muscle likely contribute.

In mice, both the autophosphorylation of IGF-1R and the sensitivity of Akt1 to IGF-1 are decreased with age ([@bib1]). Our results in young *Hnrnpu* mutants indicate that the autophosphorylation of IGF-1R in response to IGF-1 is unaltered, whereas the phospho-activation of Akt1 is desensitized to IGF-1. These observations indicate that hnRNP-U is essential for the normal signaling activities downstream of IGF-1R and suggest an hnRNP-U-independent mechanism modulates the age-associated changes in IGF-1R activation. In contrast with 1-year-old non-sarcopenic WT mice ([@bib1]), we observe Akt1 to be constitutively active under normal physiological conditions in the atrophied muscles of *Hnrnpu* mutants, suggesting that other processes, in addition to Akt activation, are required for the hypertrophic growth of muscle. Short-term activation of Akt1 signaling induces changes in the expression of genes critical for the activity of pathways involved in the production and storage of energy and nutrients ([@bib79]) in parallel with hypertrophic growth ([@bib33]; [@bib79]). Autophagy is an essential process for the maintenance of cellular homeostasis that may be further induced in response to cellular stress to reduce organelles and macromolecules into amino acids, nucleosides, fatty acids, and sugars in support of cellular growth and survival ([@bib62]). Although it is impaired by Akt/mTOR hypertrophic signaling ([@bib47]), insufficient and excessive autophagy negatively impacts muscle ([@bib46]; [@bib50]), suggesting an inflection point between an autophagic flux that supports muscle hypertrophy and that which promotes muscle wasting. The constitutive activation of Akt in *Hnrnpu* mutants coincides with both impaired autophagy and an increase in ULK1 inhibitory phosphorylation at S757 and is consistent with prior reports indicating that increased mTORC1 activity is responsible for the observed impairments in autophagy ([@bib10]; [@bib35]).

Muscle energy production may be divided into anaerobic metabolism, which provides energy from glycolysis for rapid movements, and mitochondrial regulated aerobic metabolism for sustained exercise ([@bib87]). The sensing of nutrient availability and the transport of extracellular nutrients into the cell are tightly regulated by a meshwork of interconnected signaling pathways that include Akt and mTORC1 ([@bib8]; [@bib16]). Dysregulation of energy metabolism and nutrient insufficiencies are associated with the muscle atrophy and dysfunction known to occur with advancing age, cachexia, and multiple myopathies ([@bib13]; [@bib37]; [@bib48]; [@bib60]). The transcriptional profile of *Hnrnpu* mutants indicates that genes involved in metabolic processes, including energy production, nutrient sensing and transport, and signal transduction are both repressed and mis-spliced, suggesting that their biochemical activities and/or intracellular localization is altered. The observations of constitutively active Akt, and a marked increase in PTEN expression, would suggest an increase in the demand for amino acids necessary to support hypertrophic growth ([@bib79]), as well as an increase in energy expenditures ([@bib24]). The significant increases in *Asns*, *Fgf21*, and *Gdf15* expression are consistent with a state of nutritional and metabolic stress ([@bib8]; [@bib22]; [@bib59]) and are in agreement with prior analyses of gastrocnemius muscle expressing a constitutively active form of Akt ([@bib79]). In addition, the marked increase in *Sln* would suggest an increase in mitochondrial biogenesis and oxidative metabolism ([@bib51]), whereas the increases in *Mthfd2* and *Psat1* are consistent with compensatory mechanisms to mitigate mitochondrial and oxidative stress ([@bib54]; [@bib75]; [@bib82]).

Tissue-specific and ubiquitously expressed RNA-binding proteins cooperatively interact with the regulatory elements both within a nascent transcript and of the spliceosome for context-dependent tissue-specific mRNA splicing ([@bib23]; [@bib77]). Prior reports have demonstrated the importance of skeletal muscle enriched splicing factors Rbfox1/2 ([@bib72]), RBM20 ([@bib27]), and RBM24 ([@bib81]) in the development, functionality, and growth of muscle. Skeletal muscle accounts for approximately 50% of the nearly 50-fold increase in body weight during murine post-natal development ([@bib2]). During this time, a large percentage of the transcriptome undergoes extensive temporal-dependent changes in alternative splicing that occur largely independent of changes in gene expression ([@bib7]), suggesting that the temporal changes in protein isoform expression are critical for the post-natal physiological growth of skeletal muscle. In addition, the increasing number of whole transcriptome analyses of physiologically normal, endurance trained, hypertrophic, and atrophying skeletal muscle ([@bib17]; [@bib44]; [@bib45]; [@bib70]; [@bib79]) provides unique molecular insights into its growth and adaptive responses. Our whole transcriptome analyses describe the changes in gene expression and splicing associated with the myopathy phenotype of *Hnrnpu* mutants, identifying considerable enrichment for the mis-expression/splicing of genes associated with signal transduction, metabolic processes, and inflammation. Although it may be tempting to draw conclusions based upon these observations given the seemingly ubiquitous enrichment for metabolic and inflammatory genes among these datasets, care must be taken with such interpretations given the differences in experimental models and the uncertainty of whether such transcriptome changes are the primary effect, or a compensatory effect due to changes in muscle physiology. In addition, hnRNP-U is known to enhance the transcript stability of a few select genes ([@bib86]), which may suggest that gene expression, as influenced by mRNA stability, may be similarly influenced by exon inclusion/exclusion. Although the relationship between mRNA stability and splicing is not well understood and likely regulated on a gene- and intron/exon-specific basis ([@bib12]; [@bib55]), the possibility that this may contribute to our observations is intriguing.

Collectively, our studies link *Hnrnpu* to the proper expression and splicing of genes underlying the physiological growth of skeletal muscle. Our data would suggest that the muscles of *Hnrnpu* mutants are under cellular and metabolic stress due to dysregulation of the cellular feedback mechanisms limiting Akt/mTOR signaling in response to energy and/or nutrient insufficiency. Future detailed analyses dissecting the impact of alternative splicing dysregulation on the feedback mechanism limiting Akt/mTOR may provide novel insights to the pathogenesis of muscle wasting disorders.

Limitations of the Study {#sec3.1}
------------------------

We demonstrate that loss of *Hnrnpu* in skeletal muscle causes impaired post-natal hypertrophic growth and changes in the expression and splicing of numerous genes involved in signal transduction and metabolic processes. Our data strongly suggest that impaired muscle growth due to the loss of hnRNP-U is biased toward muscles with a greater content of fast glycolytic, rather than slow oxidative, myofibers but cannot definitively confirm this observation at the level of the individual myofiber subtype. Given the temporal lag between *in vivo* Cre activation and the time point at which whole transcriptome analyses were performed, we are unable to discern between the primary and secondary effects on the transcriptome, and its impact on muscle physiology, owing to the loss of hnRNP-U. RNA-binding proteins play crucial roles in modulating the stability, structure, and splicing of transcripts ([@bib28]), making it difficult to discern between these functions as these processes are interrelated. In cell culture model systems, hnRNPU is known to bind a purine-rich consensus sequence (KGRGKRV) to modulate both the splicing of nascent transcripts ([@bib30]; [@bib80]) and the stability of mRNA ([@bib86]). Whether skeletal muscle hnRNP-U binds a similar set of nascent transcripts and enhances mRNA stability is unknown and warrants future investigations. Although our transcriptional data and signaling analyses are consistent with prior reports of cellular and metabolic stress in muscle ([@bib32]; [@bib34]; [@bib73]; [@bib75]), metabolic profiling and detailed molecular analyses of splice variant functional analyses will be needed to better understand the mechanistic linkages between splice variant expression and the regulation of Akt/mTOR signaling in muscle physiology.
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